AIM Several studies have examined the links between maternal obesity and the risk of cerebral palsy (CP) in children, with inconsistent results. The aim of our study was to investigate whether maternal obesity is associated with increased risk of CP in offspring by using meta-analysis.
RESULTS A total of five cohort studies involving 12 324 cases and 7 919 288 participants were included in our meta-analysis. The pooled crude and adjusted ORs (95% CIs) were 1.65 (1.38-1.98) and 1.51 (1.24-1.84) respectively. Additionally, the pooled OR (95% CI) for CP in offspring in relation to maternal obesity class I (body mass index [BMI] 30.0-34.9), class II (BMI 35.0-39.9), and class III (BMI≥40.0) compared with normal weight during prepregnancy or pregnancy was 1.31 (1.15-1.50), 1.65 (1.34-2.02), and 2.37 (1.91-2.94) respectively.
INTERPRETATION This meta-analysis demonstrated that increasing grades of maternal obesity are associated with a higher risk of CP in offspring.
Cerebral palsy (CP) is an umbrella term for a highly heterogeneous group of disorders, which are characterized by disturbances in body motor function caused by nonprogressive lesion of the infant or fetal brain. 1 CP is the most common pediatric motor disability, occurring in two to four per 1000 children. 2, 3 CP has a great impact on children and their families, involving lifetime disability, a shortened life expectancy, chronic diseases, and financial costs. 4, 5 However, the underlying pathogenesis of CP remains largely unknown. Etiological studies have suggested that some perinatal factors, including preterm delivery, intrauterine growth restriction, and birth asphyxia, are known to affect the risk of CP. 6 Although preterm birth is strongly associated with CP, most children with CP are born at term. Moreover, despite perinatal care improving in recent years, the prevalence of CP has not declined. [7] [8] [9] This suggests that prenatal factors, including maternal conditions and infection during pregnancy or prepregnancy, may be important to the pathogenesis of CP. 10 Maternal obesity, which has become a global health problem over the past 30 years, is one of the most common prenatal risk factors associated with adverse effects in both mother and child health, including pre-eclampsia, gestational diabetes mellitus, preterm delivery, macrosomia, obstetric complications, stillbirth, and neonatal morbidities. [11] [12] [13] [14] [15] Moreover, many studies suggest that maternal obesity induces a chronic inflammation that could detrimentally affect fetal brain development 16, 17 and is associated with neurodevelopmental and neuropsychiatric disorders in children including autism spectrum disorders, cognitive impairment, schizophrenia, attention-deficit/hyperactivity disorder, and depression with an age span from 6 months to 15 years. [18] [19] [20] [21] [22] [23] An association between maternal obesity and the risk of CP in children has also been observed by several epidemiological studies. [24] [25] [26] [27] [28] [29] [30] [31] [32] However, the results were inconclusive. Some epidemiological studies reported that exposure to maternal obesity in utero was associated with an increased risk of CP, 24, 25, [28] [29] [30] [31] whereas others reported no statistically significant association. 26, 27, 32 Therefore, we undertook a meta-analysis of published observational studies to address the question of whether maternal obesity was associated with increased risk of CP in children. Evidence of an association between maternal obesity and later CP in the offspring could help to illuminate the pathogenetic mechanism of this disorder.
METHOD Literature search and selection criteria
This meta-analysis was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. Relevant studies examining maternal obesity and risk of CP in children were identified by searching the PubMed and Web of Science databases in August 2017 with search terms of ((Obesity OR Pre-pregnancy OR body mass index [BMI] OR Maternal OR Perinatal)) AND Cerebral palsy. Two authors independently evaluated the retrieved studies from databases and references by screening the title, abstract, or full text to assess their eligibility according to the inclusion criteria (see below).
Observational studies, including case-control and cohort study, that investigated the association between maternal obesity and CP in children were included in this meta-analysis if they met the following criteria: (1) maternal obesity (BMI≥30) and CP in children was reported; (2) a comparison group was included; (3) the article provided sufficient data, either an odds ratio (OR), hazard ratio, or risk ratio was reported; (4) the sample size was larger than 10. Reviews, animal studies, case reports, conference abstract, and simple commentaries were excluded.
Data extraction and quality assessment
The following data were extracted from the included studies: first-named author, publication year, study duration and design, study location, sample size, potential confounders considered, and outcome parameters (ORs, hazard ratios, and risk ratios) and their corresponding 95% confidence intervals (CIs). The methodological quality of the included studies was assessed by using the NewcastleOttawa Scale.
22,33

Statistical analysis
To estimate the association between maternal obesity and CP in children, data from the included studies were combined and analyzed by using STATA 12 (StataCorp, College Station, TX, USA). The hazard ratios and risk ratios were considered equivalent to ORs because the prevalence of CP is sufficiently rare (of the order of 2-4 per 1000 live births). 18, 22, [28] [29] [30] [31] [32] We analyzed both the adjusted and crude estimates from the included studies. A fixed-effects model was used to calculate the pooled OR as well as its 95% CI when the heterogeneity was low; otherwise, a random-effects model was adopted. Heterogeneity across the included studies was assessed using the I 2 inconsistency test and v
2
-based Cochran Q statistic test. 22 The heterogeneity was considered to be low, moderate, or high according to I 2 values of 25%, 50%, and 75% respectively. 22 A p-value from the Q test of less than 0.1 and I 2 of over 50% indicated high heterogeneity. To identify resources of potential heterogeneity in this study, subgroup analyses were conducted across some key study characteristics, including obese classes (I, II, III), sample size (<8000 or ≥8000), location, study design, BMI measurement, adjustment for maternal age (yes, no), smoking during pregnancy (yes, no), and child sex (yes, no). Publication bias was evaluated by using a funnel plot and Egger's statistical test (significance level of p<0.05).
RESULTS
Literature search
A total of 768 relevant records were retrieved from electronic databases. After screening titles and abstracts, 753 articles were excluded. After assessing the eligibility of the full text of the remaining 15 articles, 10 articles comprising four studies with no necessary data, [24] [25] [26] [27] three reviews, 18, 20, 34 two commentaries, 35, 36 and one study with irrelevant topics 37 were excluded. Finally, five observational studies [28] [29] [30] [31] [32] were included in this study. A detailed flow diagram of the search and selection process in accordance with PRISMA is presented in Figure S1 (online supporting information).
Study characteristics
The five cohort studies represent a total of 12 324 cases and 7 919 288 participants were eligible and included in this meta-analysis. [28] [29] [30] [31] [32] The characteristics of the five included studies are listed in Table I . Among the studies, two clearly pointed out the gestational age, 30 ,32 three clearly pointed out that they included infants born preterm, 28, 30, 32 one mentioned the average age of the offspring, 30 and four gave approximate descriptions of the age of offspring. 28, 29, 31, 32 The age range of offspring in these studies was 2 to 15 years (Table I) . Four studies were conducted in the USA and one study was from Europe. The maternal obesity criteria were defined with prepregnancy BMI of greater than or equal to 30 in most studies. The crude and adjusted ORs, hazard ratios, and risk ratios and their corresponding 95% CIs in the included studies are also shown in Table I . The Newcastle-Ottawa Scale quality assessment of the five studies obtained more than six out of nine stars, indicating that the methodological quality of the included studies was adequate (Table II) .
Meta-analysis
The meta-analysis on the five included studies suggested a significant positive association between maternal obesity and the risk of CP in children, assuming a random-effects model (pooled crude OR 1.65, 95% CI: 1.38-1.98, Z=5.43, p<0.001) (Fig. 1) . High heterogeneity was observed between studies (I 2 =69.6%, p<0.001). The results remained significant after using the adjusted OR from the included studies (pooled adjusted OR 1.51; 95% CI: 1.24-1.84, Z=4.15, p<0.001; Fig. 2 ).
What this paper adds
• Meta-analysis demonstrates a significant positive association between maternal obesity and the risk of cerebral palsy (CP) in children.
• Subgroup analysis indicates that higher grades of maternal obesity are associated with increasing risk of CP. Hazard ratios (HRs) and risk ratios (RRs) were considered equivalent to odds ratios (ORs) because the prevalence of CP is sufficiently rare. 
Subgroup analysis
A summary of all the main and subgroup meta-analyses of the association between maternal obesity and the risk of CP in children stratified by obese class, sample size, location, study design, BMI measurement, and adjustment for confounders is provided in (Fig. 3 and Table III ). This indicated that increasing grades of maternal obesity were associated with increasing risk of CP in offspring. 30 Stronger associations between maternal obesity and risk of CP in children were found in which BMI was measured at pregnancy and in the USA studies (Table III) . Additionally, stronger associations between maternal obesity and risk of CP in children were found in studies adjusted for child sex and maternal age than in studies that did not adjust for such confounders (Table III) .
Publication bias
There was no evidence of significant publication bias among the included studies in this meta-analysis according to the funnel plot (Fig. 4) and Egger's test (p=0.117).
DISCUSSION
Results from our current meta-analysis of observational studies indicate that maternal obesity is significantly positively associated with the risk of CP in offspring. This is consistent with other studies demonstrating the associations between maternal prepregnancy and pregnancy obesity and the risk of neurodevelopmental disabilities and psychiatric disorders such as cognitive impairment, autism spectrum disorders, attention-deficit/hyperactivity disorder, schizophrenia, and depression in children. [18] [19] [20] [21] [22] [23] As far as we know, maternal obesity is associated with an increased risk of pregnancy complications, including preterm delivery, pre-eclampsia, gestational diabetes, and asphyxia-related neonatal complications, which in turn are associated with an increased risk of CP in children. 6, 10 However, more than 70% of children with 
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Although the causal pathway of the association between maternal prepregnancy and pregnancy obesity, and the risk of CP in children remains to be elucidated, there are several hypotheses to explain the effects of maternal obesity on CP and other neurodevelopmental and psychiatric disorders. 18, 22 One hypothesis is that obesity-induced chronic systemic inflammation before and during pregnancy leads to a cascading series of events that affect fetal brain development and neurodevelopmental functioning, 16, 18, [38] [39] [40] which is the most prevailing mechanism to explain the association between maternal obesity and risk of CP in children.
It is known that obese pregnant mothers have higher levels of C-reactive protein and inflammatory cytokines including interleukin-1, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in plasma and placentas, than pregnant mothers with normal weight. [40] [41] [42] Elevated maternal C-reactive protein and pro-inflammatory cytokine levels during pregnancy are associated with increased risk of neurodevelopmental and psychiatric disorders in offspring. [43] [44] [45] Additionally, intrauterine and placental inflammatory milieu are associated with fetal neurodevelopmental damage and altered gene expression in the neonatal brain. [43] [44] [45] Furthermore, animal model studies showed that obesity induced by a high-fat diet during pregnancy alters fetal brain inflammatory signaling, which has downstream effects on microglial functioning, brain development, and subsequent neuropsychiatric disorders in children. 16, 18, 38, 40 Except for maternal obesity, paternal obesity has also been found to be associated with increased risk of neurodevelopmental disabilities such as autism spectrum disorders and attention-deficit/hyperactivity disorder in children. 46, 47 Among the included observational studies in our meta-analysis on maternal obesity and CP, only one took paternal BMI into account. 31 Unfortunately, it found no association between paternal obesity and risk of CP in children. 31 However, recent studies have found that a parental highfat diet mouse model renders offspring more susceptible to developing diabetes and obesity in a sex and parent of origin-specific mode by using in vitro fertilization to ensure exclusive inheritance via the gametes. 48, 49 Therefore, paternal obesity should be an important confounding factor for the risk of CP in children with obese mothers.
As far as we know, our present study is the first meta-analysis to explore maternal obesity and the risk of CP in children. However, there are some limitations that should be emphasized. First, the association between maternal obesity and CP in children may be due to unmeasured confounders such as genetic or shared family environmental factors. Therefore, future research should explore and focus on the potential underlying genetic and epigenetic mechanisms for maternal obesity and CP in children. Second, maternal obesity was self-reported without quality assessment, and the different CP definitions used in observational studies may have led to bias because of diverse criteria. Third, the hazard ratios and risk ratios were considered equivalent to ORs given that the prevalence of CP is sufficiently rare. Fourth, we did not focus on gestational weight gain and the risk of CP in offspring because of the limited number of studies that examined this variable. Finally, high heterogeneity was found between studies, but we could not perform metaregression analyses to identify the sources of heterogeneity because of the limited number of studies included. 18 
CONCLUSIONS
Our meta-analysis has demonstrated a significant positive association between maternal obesity and the risk of CP in children; however, the underlying mechanism for this association remains to be confirmed. Further research should focus on the replication of these findings and the elucidation of the key mechanisms that underlie this relationship. The significant clinical implications at this time suggest that encouraging weight loss before pregnancy and minimizing gestational weight gain during pregnancy are the most effective and safest methods for mitigating risk of CP in offspring. 2015A030310025, 2016A0303104) ; the Guangzhou Technologic Programme Foundation (2014Y2-00115); and the National Undergraduate Training Program for Innovation and Entrepreneurship (201612121007). The funding had no further role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. The authors have stated that they had no interests that could be perceived as posing a conflict or bias.
SUPPORTING INFORMATION
The following additional material may be found online. Figure S1 : Flow chart of the study selection process to identify studies eligible for the systematic review. OBJETIVO Varios estudios han examinado la relaci on entre obesidad materna y riesgo de par alisis cerebral (PC) en niños, con resultados inconsistentes. El objetivo de nuestro estudio fue investigar si la obesidad materna est a asociada a riesgo aumentado de PC en la descendencia utilizando un metaan alisis.
